Recursion Pharmaceuticals Stock Price History
| RXRX Stock | USD 5.84 0.32 5.80% |
Below is the normalized historical share price chart for Recursion Pharmaceuticals extending back to April 16, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Recursion Pharmaceuticals stands at 5.84, as last reported on the 21st of July, with the highest price reaching 6.23 and the lowest price hitting 5.52 during the day.
If you're considering investing in Recursion Stock, it is important to understand the factors that can impact its price. Recursion Pharmaceuticals appears to be risky, given 3 months investment horizon. Recursion Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0379, which implies the firm had a 0.0379 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Recursion Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Recursion Pharmaceuticals' Coefficient Of Variation of 2315.61, semi deviation of 5.34, and Risk Adjusted Performance of 0.0487 to confirm if our risk estimates are consistent with your expectations.
At this time, Recursion Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.5 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 212.6 M in 2025. . At this time, Recursion Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.88 in 2025, whereas Price To Sales Ratio is likely to drop 29.93 in 2025. Recursion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2021 | 200 Day MA 6.2429 | 50 Day MA 4.8886 | Beta 0.833 |
Recursion | Build AI portfolio with Recursion Stock |
Sharpe Ratio = 0.0379
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RXRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.6 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Recursion Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Recursion Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.7112 | Enterprise Value Ebitda (5.31) | Price Sales 42.3497 | Shares Float 388.5 M | Wall Street Target Price 7.1429 |
Recursion Pharmaceuticals Stock Price History Chart
There are several ways to analyze Recursion Stock price data. The simplest method is using a basic Recursion candlestick price chart, which shows Recursion Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 28, 2025 | 5.84 |
| Lowest Price | May 23, 2025 | 4.08 |
Recursion Pharmaceuticals July 21, 2025 Stock Price Synopsis
Various analyses of Recursion Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Recursion Stock. It can be used to describe the percentage change in the price of Recursion Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Recursion Stock.| Recursion Pharmaceuticals Price Action Indicator | 0.13 | |
| Recursion Pharmaceuticals Price Daily Balance Of Power | 0.45 | |
| Recursion Pharmaceuticals Price Rate Of Daily Change | 1.06 |
Recursion Pharmaceuticals July 21, 2025 Stock Price Analysis
Recursion Stock Price History Data
The price series of Recursion Pharmaceuticals for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 1.76 with a coefficient of variation of 10.52. The price distribution for the period has arithmetic mean of 5.03. The median price for the last 90 days is 5.16.| Open | High | Low | Close | Volume | ||
07/21/2025 | 5.52 | 6.23 | 5.52 | 5.84 | ||
07/21/2025 | 5.52 | 6.23 | 5.52 | 5.84 | ||
07/18/2025 | 5.65 | 6.23 | 5.57 | 5.84 | 52,930,036 | |
| 07/17/2025 | 5.48 | 5.74 | 5.46 | 5.52 | 27,419,040 | |
07/16/2025 | 5.31 | 5.56 | 5.21 | 5.39 | 24,254,559 | |
| 07/15/2025 | 5.31 | 5.53 | 5.13 | 5.22 | 29,037,296 | |
07/14/2025 | 5.25 | 5.42 | 5.19 | 5.28 | 20,420,650 | |
07/11/2025 | 5.56 | 5.61 | 5.25 | 5.28 | 31,616,145 | |
| 07/10/2025 | 5.71 | 5.88 | 5.57 | 5.72 | 28,629,175 | |
07/09/2025 | 5.46 | 5.77 | 5.43 | 5.59 | 34,533,696 | |
| 07/08/2025 | 5.01 | 5.63 | 5.00 | 5.36 | 45,293,795 | |
07/07/2025 | 5.18 | 5.22 | 4.80 | 4.93 | 37,317,013 | |
| 07/03/2025 | 5.24 | 5.33 | 5.15 | 5.27 | 16,582,108 | |
| 07/02/2025 | 5.15 | 5.40 | 5.08 | 5.21 | 25,011,190 | |
07/01/2025 | 5.00 | 5.44 | 4.91 | 5.13 | 37,991,094 | |
| 06/30/2025 | 5.10 | 5.27 | 5.01 | 5.06 | 25,729,824 | |
06/27/2025 | 5.39 | 5.48 | 4.98 | 5.03 | 46,518,741 | |
06/26/2025 | 5.03 | 5.43 | 4.98 | 5.40 | 21,512,359 | |
06/25/2025 | 5.36 | 5.36 | 4.96 | 5.16 | 20,880,008 | |
06/24/2025 | 5.00 | 5.31 | 4.99 | 5.22 | 22,974,666 | |
06/23/2025 | 4.88 | 5.05 | 4.72 | 4.83 | 21,545,400 | |
06/20/2025 | 5.23 | 5.36 | 4.90 | 5.03 | 32,034,642 | |
| 06/18/2025 | 4.83 | 5.25 | 4.80 | 5.11 | 35,093,167 | |
06/17/2025 | 4.90 | 5.09 | 4.78 | 4.84 | 21,238,137 | |
| 06/16/2025 | 5.01 | 5.08 | 4.83 | 5.00 | 27,152,580 | |
06/13/2025 | 4.96 | 5.15 | 4.84 | 4.92 | 37,504,925 | |
06/12/2025 | 5.25 | 5.41 | 5.13 | 5.17 | 28,262,762 | |
06/11/2025 | 5.65 | 5.79 | 5.34 | 5.40 | 33,020,404 | |
06/10/2025 | 5.43 | 6.07 | 5.36 | 5.45 | 48,170,946 | |
06/09/2025 | 5.84 | 5.84 | 5.32 | 5.37 | 46,852,706 | |
06/06/2025 | 4.72 | 5.52 | 4.71 | 5.49 | 60,110,596 | |
06/05/2025 | 4.92 | 4.96 | 4.44 | 4.57 | 32,939,770 | |
| 06/04/2025 | 4.45 | 5.08 | 4.41 | 4.91 | 45,850,071 | |
06/03/2025 | 4.43 | 4.43 | 4.22 | 4.39 | 16,282,986 | |
06/02/2025 | 4.18 | 4.52 | 4.18 | 4.37 | 19,101,793 | |
05/30/2025 | 4.35 | 4.36 | 4.11 | 4.18 | 20,495,483 | |
05/29/2025 | 4.49 | 4.67 | 4.36 | 4.45 | 21,731,586 | |
05/28/2025 | 4.50 | 4.69 | 4.38 | 4.39 | 23,122,624 | |
05/27/2025 | 4.20 | 4.48 | 4.10 | 4.39 | 22,764,740 | |
05/23/2025 | 4.01 | 4.14 | 3.96 | 4.08 | 16,720,774 | |
05/22/2025 | 4.16 | 4.25 | 4.02 | 4.14 | 16,692,556 | |
05/21/2025 | 4.43 | 4.49 | 4.05 | 4.10 | 22,540,468 | |
05/20/2025 | 4.50 | 4.65 | 4.40 | 4.55 | 14,638,390 | |
05/19/2025 | 4.36 | 4.51 | 4.26 | 4.51 | 14,064,098 | |
| 05/16/2025 | 4.43 | 4.64 | 4.31 | 4.56 | 22,473,193 | |
05/15/2025 | 4.24 | 4.29 | 4.12 | 4.25 | 13,517,980 | |
05/14/2025 | 4.60 | 4.72 | 4.28 | 4.31 | 22,339,984 | |
05/13/2025 | 4.66 | 4.75 | 4.47 | 4.51 | 18,940,412 | |
05/12/2025 | 4.63 | 4.68 | 4.41 | 4.64 | 24,478,966 | |
05/09/2025 | 4.52 | 4.63 | 4.31 | 4.33 | 14,800,648 | |
05/08/2025 | 4.32 | 4.57 | 4.14 | 4.39 | 27,231,671 | |
| 05/07/2025 | 4.33 | 4.38 | 4.11 | 4.19 | 22,493,187 | |
05/06/2025 | 4.66 | 4.68 | 4.15 | 4.16 | 31,580,806 | |
05/05/2025 | 5.49 | 5.80 | 4.75 | 4.76 | 34,461,440 | |
05/02/2025 | 5.61 | 5.90 | 5.60 | 5.70 | 19,809,825 | |
05/01/2025 | 5.68 | 5.70 | 5.46 | 5.50 | 12,896,985 | |
04/30/2025 | 5.47 | 5.63 | 5.24 | 5.59 | 14,923,970 | |
04/29/2025 | 5.87 | 5.94 | 5.68 | 5.72 | 10,666,176 | |
04/28/2025 | 5.78 | 6.07 | 5.68 | 5.84 | 13,824,701 | |
04/25/2025 | 5.62 | 5.84 | 5.54 | 5.73 | 12,699,337 | |
04/24/2025 | 5.60 | 5.78 | 5.58 | 5.75 | 13,322,108 |
About Recursion Pharmaceuticals Stock history
Recursion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Recursion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Recursion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Recursion Pharmaceuticals stock prices may prove useful in developing a viable investing in Recursion Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 274.2 M | 212.6 M | |
| Net Loss | -215.5 M | -226.3 M |
Recursion Pharmaceuticals Quarterly Net Working Capital |
|
Recursion Pharmaceuticals Stock Technical Analysis
Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Recursion Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Recursion Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Recursion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Recursion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0487 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0176 | |||
| Treynor Ratio | 0.085 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.